Annual Interest Expense
$42.30 K
-$15.90 K-27.32%
31 December 2023
Summary:
Silence Therapeutics annual interest expense is currently $42.30 thousand, with the most recent change of -$15.90 thousand (-27.32%) on 31 December 2023. During the last 3 years, it has risen by +$21.80 thousand (+106.34%). SLN annual interest expense is now -67.03% below its all-time high of $128.30 thousand, reached on 31 December 2004.SLN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$11.19 M
+$10.96 M+4747.60%
01 September 2024
Summary:
Silence Therapeutics quarterly interest expense is currently $11.19 million, with the most recent change of +$10.96 million (+4747.60%) on 01 September 2024. Over the past year, it has increased by +$11.18 million (+110722.77%). SLN quarterly interest expense is now at all-time high.SLN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$11.36 M
+$11.18 M+6237.03%
01 September 2024
Summary:
Silence Therapeutics TTM interest expense is currently $11.36 million, with the most recent change of +$11.18 million (+6237.03%) on 01 September 2024. Over the past year, it has increased by +$9.17 million (+419.21%). SLN TTM interest expense is now at all-time high.SLN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.3% | +10000.0% | +419.2% |
| 3 y3 years | +106.3% | +10000.0% | +1560.4% |
| 5 y5 years | +100.0% | - | - |
SLN Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -27.3% | +284.6% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5 years | -27.3% | at high | +8336.3% | at high | >+9999.0% | |
| alltime | all time | -67.0% | at high | +8336.3% | at high | >+9999.0% |
Silence Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.19 M(+4747.6%) | $11.36 M(+6237.0%) |
| June 2024 | - | $230.90 K(+1299.4%) | $179.30 K(-83.2%) |
| Mar 2024 | - | $16.50 K(-121.1%) | $1.07 M(-49.1%) |
| Dec 2023 | $42.30 K(-27.3%) | -$78.20 K(-874.3%) | $2.09 M(-4.3%) |
| Sept 2023 | - | $10.10 K(-99.1%) | $2.19 M(-1.3%) |
| June 2023 | - | $1.12 M(+6.9%) | $2.22 M(+101.6%) |
| Mar 2023 | - | $1.05 M(+6732.0%) | $1.10 M(+1890.2%) |
| Dec 2022 | $58.20 K(+429.1%) | $15.30 K(-61.8%) | $55.30 K(-184.9%) |
| Sept 2022 | - | $40.00 K(>+9900.0%) | -$65.10 K(+285.2%) |
| June 2022 | - | $0.00(0.0%) | -$16.90 K(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | -$16.90 K(-102.4%) |
| Dec 2021 | $11.00 K | -$105.10 K(-219.2%) | $715.10 K(+4.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $88.20 K(>+9900.0%) | $684.30 K(-8.7%) |
| June 2021 | - | $0.00(-100.0%) | $749.90 K(0.0%) |
| Mar 2021 | - | $732.00 K(-638.6%) | $749.90 K(+4089.4%) |
| Dec 2020 | $20.50 K(-51.3%) | -$135.90 K(-188.4%) | $17.90 K(-88.4%) |
| Sept 2020 | - | $153.80 K | $153.80 K |
| Dec 2019 | $42.10 K(>+9900.0%) | - | - |
| Dec 2018 | $0.00(-100.0%) | - | - |
| Dec 2017 | $19.40 K(-6.7%) | - | - |
| Dec 2011 | $20.80 K(-78.6%) | - | - |
| Dec 2010 | $97.10 K(+5294.4%) | - | - |
| Dec 2006 | $1800.00(0.0%) | - | - |
| Dec 2005 | $1800.00(-98.6%) | - | - |
| Dec 2004 | $128.30 K | - | - |
FAQ
- What is Silence Therapeutics annual interest expense?
- What is the all time high annual interest expense for Silence Therapeutics?
- What is Silence Therapeutics annual interest expense year-on-year change?
- What is Silence Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Silence Therapeutics?
- What is Silence Therapeutics quarterly interest expense year-on-year change?
- What is Silence Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Silence Therapeutics?
- What is Silence Therapeutics TTM interest expense year-on-year change?
What is Silence Therapeutics annual interest expense?
The current annual interest expense of SLN is $42.30 K
What is the all time high annual interest expense for Silence Therapeutics?
Silence Therapeutics all-time high annual interest expense is $128.30 K
What is Silence Therapeutics annual interest expense year-on-year change?
Over the past year, SLN annual interest expense has changed by -$15.90 K (-27.32%)
What is Silence Therapeutics quarterly interest expense?
The current quarterly interest expense of SLN is $11.19 M
What is the all time high quarterly interest expense for Silence Therapeutics?
Silence Therapeutics all-time high quarterly interest expense is $11.19 M
What is Silence Therapeutics quarterly interest expense year-on-year change?
Over the past year, SLN quarterly interest expense has changed by +$11.18 M (+110722.77%)
What is Silence Therapeutics TTM interest expense?
The current TTM interest expense of SLN is $11.36 M
What is the all time high TTM interest expense for Silence Therapeutics?
Silence Therapeutics all-time high TTM interest expense is $11.36 M
What is Silence Therapeutics TTM interest expense year-on-year change?
Over the past year, SLN TTM interest expense has changed by +$9.17 M (+419.21%)